Global Amoxicillin Market Size, Share and Trends Analysis Report, By Application (Skin Infections, ENT Infections, Stomach Infections, Lungs Infections, Urinary tract infections (UTI), Pneumonia, Bronchitis, and Gonorrhea) Forecast (2022-2028)

The global amoxicillin market is anticipated to grow at a significant CAGR of 1.2% during the forecast period (2022-2028). Amoxicillin is used to treat certain infections caused by bacteria, such as pneumonia, bronchitis, and infections of the ears, nose, throat, urinary tract, and skin. It is also used in combination with other medications to eliminate helicobacter pylori. The global amoxicillin market is growing due to the rising prevalence of bacterial and fungus infections globally. According to an article published by The Oxford University in January 2022, 1.2 million people died globally due to antibiotic-resistant bacterial infection. According to Central Disease Control and Prevention, 75,000 hospitalizations and 9 million outpatient visits for fungal diseases were reported in the US alone in 2017. Additionally, increasing government awareness for encouraging timely diagnosis and treatment of bacterial and fungal infections is anticipated to propel the growth of the global amoxicillin market during the forecast period.

 

The market player is also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and launches, to stay competitive in the market. For instance-

 

• In August 2021, Jackson Healthcare announced the reopening of the Bristol, Tenn. manufacturing facility of 360,000 sq. ft. which will be used for the production of penicillin-based amoxicillin and Amoxil clavulanate.
• In May 2021, Sandoz International GmbH announced to invest $171.3 million for new antibiotics manufacturing technology in Europe over the next three to five years. This plan further states to strengthen its European antibiotics manufacturing network by further expanding production capabilities in Kundl, Austria, and Palafolls, Spain.
• In January 2020, WOCKHARDT received approval from the Drug Controller General of India for ‘Emrok’ in injection and oral route of administration form to get the nod for novel antibiotics that will be used to treat acute bacterial skin and skin structure infections, including diabetic foot infections.
• In July 2019, World Health Organization announced ceftazidime-avibactam, meropenem-vaborbactam, and plazomicin as the essential medicine list which will target multidrug-resistant infections caused by pathogens.

 

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Drug Form
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Competitive Landscape–  BRP Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Jackson Healthcare, Novartis AG, Sanis Health Inc., and Sun Pharmaceutical Industries Ltd., among others.

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Amoxicillin Market Report by Segment

By Application

• Skin Infections
• ENT Infections
• Stomach Infections
• Lungs Infections
• Urinary tract infections (UTI)
• Pneumonia
• Bronchitis
• Gonorrhea

 

Global Amoxicillin Market Report by Region

 

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa